ng-nitroarginine methyl ester has been researched along with Rhabdomyolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Högner, A; Lai, EY; Liu, ZZ; Mathia, S; Pahlitzsch, T; Patzak, A; Persson, PB; Rosenberger, C; Schubert, R; Wennysia, IC; Xu, MZ | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Rhabdomyolysis
Article | Year |
---|---|
Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
Topics: Angiotensin II; Animals; Antioxidants; Arterioles; Calcium Signaling; Cyclic N-Oxides; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney; Male; Mice, Inbred C57BL; Microscopy, Video; Myoglobin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rhabdomyolysis; Spin Labels; Superoxides; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2017 |